Business
Posting of Notice of GM and Annual Report
Posting of Notice of GM and Annual Report.
About this update from Edx Medical Group Plc
[{"type":"text","content":"\n\n \n\n \nPosting of Notice of GM and Annual Report\nEDX Medical Group plc · EDX\n \n2 October 2023\nEDX Medical Group plc (\"EDX Medical\" or the \"Company\"), which develops innovative digital diagnostic products and services supporting personalised treatment solutions for cancer, heart disease, neurology and infectious diseases, announces that a general meeting (\"GM\") will be held at 10 Stratton Street, London W1J 8LG on 25 October 2023 at 2:00 p.m.\nThe annual report and financial statements for the year ended 31 March 2023, Notice of GM and Form of Proxy will be posted today, 2 October 2023, to eligible shareholders. Electronic copies will be shortly available on the Company's website at: https://edxmedical.co.uk/documents/.\n \nContacts:\n\n\n\nEDX Medical plc\n\n\n\n\n\n\n\n\nDr Mike Hudson (Chief Executive Officer)\n\n\n+44 (0)7812 345 301\[email protected]\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nOberon Capital\n\n\n\n\n\n\n\n\nNick Lovering (Corporate Adviser)\nAdam Pollock (Corporate Broking)\nMike Seabrook (Corporate Broking)\n\n\n+44 (0)20 3179 5300\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMedia House International\n\n\n\n\n\n\n\n\nRamsay Smith (Executive Director)\n \nGary McQueen (Associate Director)\n\n\n+44 (0)7788 414856\[email protected]\n+ 44 (0)7834 694609\[email protected]\n\n\n\n \nNotes for Editors:\nAbout EDX Medical Group plc (www.edxmedical.co.uk)\nEDX Medical Group plc develops innovative digital diagnostic products and services, enabling cost effective and timely delivery of personalised treatment for cancer, heart disease, and infectious diseases. The company is listed on the AQSE Growth Market (TIDM: EDX).\n \nEDX Medical was founded by Professor Sir Christopher Evans, OBE, a medical and life sciences entrepreneur with more than 30 years of experience, together with CEO, Dr Mike Hudson.\n \nBy translating clinical insights into pragmatic solutions combining advanced biological and digital technologies, EDX Medical seeks to cost-effectively improve the detection and characterisation of disease in order to personalise treatment in a timely fashion. Early disease detection and biologically-based personal treatment optimisation is considered to be the most impactful way of reducing deaths and lowering the cost of healthcare globally.\n ...